A simple high-performance liquid chromatography assay for simultaneous measurement of adenosine, guanosine, and the oxypurine metabolites in plasma

Therapeutic Drug Monitoring

Volumn 22, Issue 2, 2000, Pages 177-183

  Feng, Joe D Z ^a   Yeung, Pollen K F ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adenosine; HPLC; Oxypurines; Pharmacokinetics; Plasma

Indexed keywords

3,7 DIMETHYL URIC ACID; ADENOSINE; GUANOSINE; HYDROXYPURINE; HYPOXANTHINE; INOSINE; UNCLASSIFIED DRUG; URIC ACID; XANTHINE;

ARTICLE; BLOOD SAMPLING; CHEMICAL STRUCTURE; DIAGNOSTIC VALUE; DRUG DETERMINATION; DRUG METABOLISM; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SOLID PHASE EXTRACTION;

ADENOSINE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GUANOSINE; HUMANS; HYPOXANTHINE; INOSINE; PURINES; RATS; RATS, SPRAGUE-DAWLEY; SENSITIVITY AND SPECIFICITY; URIC ACID; XANTHINE;

EID: 0034072428     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200004000-00007     Document Type: Article

References (30)

1. Berne R. The role of adenosine in the regulation of coronary blood flow. Circ Res 1980;47:807-813.
2. Gerlach E, Becker BF, and Nees S, eds. Formation of adenosine by vascular endothelium: a homeostatic and antithrombogenic mechanism? New York NY: Springer-Verlag, 1987:309-320.
3. Ashraf M, Ahmad, S. Calcium preconditioning elicits a unique protection against the calcium paradox injury in rat heart: Role of adenosine. Circ Res 1993;74:360-367.
4. Kitakaze M, Hori M, Morioka T, et al. Infarct size-Limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release. Circulation 1994;89:1237-1246.
5. Deckert J, Gleiter C. Adenosine - An endogenous neuroprotective metabolite and neuromodulator. J Neural Transm Suppl 1994; 43:23-31.
6. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension 1991;18:565-574.
7. Ely SW, Berne RM. Protective effects of adenosine in myocardial ischemia. Circulation 1992;85:893-904.
8. Sollevi A. Cardiovascular effects of adenosine in man: possible clinical implications. Prog Neurobiol 1986;27:319-349.
9. Round S, Hsieh L, Agarwal K. Effects of endotoxin injury on endothelial cell adenosine metabolism. J Lab Clin Med 1994;123: 309-317.
10. Ford DA, Sharp JA, Rovetto MJ. Erythrocyte adenosine transport: effects of Ca2+ channel antagonists and ions. Am J Physiol 1985; 248:H593-H598.
11. Rovetto MJ, Ford DA. Inhibition of adenosine transport by verapamil and other calcium channel antagonists. Prog Clin Biol Res 1987;230:223-233.
12. Phillis JW, O'Regan MH, Walter GA. Effects of nifedipine and felodipine on adenosine and inosine release from the hypoxemic rat cerebral cortex. J Cereb Blood Flow Metab 1988;8:179-185.
13. Dilorio P, Ballerini P, Ciccarelli R, Tacconelli L, Caciagli F. Sodium and calcium dependence of purine release from rat cerebral cortical slices. Pharmacol Res Commun 1988;20:511-525.
14. Melzig M, Teuscher E. Influence of vasoactive drugs on uptake of 3H-adenosine by endothelial cells. Pharmazie 1988;43:549-550.
15. Yeung PKF, Mosher SJ, MacRae DA, Klassen G A. Effect of diltiazem and its metabolites on the uptake of adenosine in blood: An in-vitro investigation. J Pharm Pharmacol 1991;43:685-689.
16. Zhane Y, Lautt W. Effects of the liver on circulating adenosine in blood. Can J Physiol Pharmacol 1993;71:874-878.
17. Yeung P, Mosher S, Li R, et al. Erythrocyte adenosine transport: A rapid screening test for cardiovascular drugs. J Pharmacol Meth 1993;30:163-167.
18. Fredholm B, Lindstrom K, Wallman-Johansson A. Propentofylline and other adenosine transport inhibitors increase the efflux of adenosine following electrical or metabolic stimulation of rat hippocampal slices. J Neurochem 1994;62:563-573.
19. Plagemann PG, Wohlhueter RM, Kraupp M. Adenosine uptake, transport, and metabolism in human erythrocytes. J Cell Physiol 1985;125:330-336.
20. Moser GH, Schrader J, Deussen A. Turnover of adenosine in plasma of human and dog blood. Am J Physiol 1989;256: C799-C806.
21. Gewirtz H, Brown P, Most AS. Measurement of plasma adenosine concentration: methodological and physiological considerations. Proc Soc Exp Biol Med 1987;185:93-100.
22. Hill J, Utterback D, Keim S, Dugger D, Mayfield W, Shryock J, Belardinelli L. A catheter-syringe sampling system for measurement of adenosine in coronary sinus blood in humans. Coron Arten Dis 1992;3:963-971.
23. Holland K, Washington J, Moe D, Conroy C. Alumina-based stationary phases for HPLC application. Am Lab 1992;Aug:51-62.
24. Thompson C, Sparks H, Spielman W. Renal handling and production of plasma and urinary adenosine. Am J Physiol 1985;248: F545-551.
25. Zhang Y, Geiger J, Lautt W. Improved high-pressure liquid chromatographic-fluorometric assay for measurement of adenosine in plasma. Gastrointest Liver Physiol 1991; 23:G658-G664.
26. Herrmann S, Feigl E. Subtraction method for the high-performance liquid chromatographic measurement of plasma adenosine. J Chromatogr B Biomed Sci Appl 1992;574:247-253.
27. Pfadenhauer EH, Tong S. Determination of inosine and adenosine in human plasma using high-performance liquid chromatography and a boronate affinity gel. J Chromatogr 1979;162:585-590.
28. Yeung P, Buckley S, Pedder S, Dingemanse J. Determination of 3, 4-dihydroxyphenylacetic acid and 5-hydroxyindoleacetic acid in human plasma by a simple and rapid high-performance liquid chromatography assay. J Pharm Sci 1996;85:451-453.
29. Tykarski A, Gluszek J, Banaszak F. Value of oxypurines and uric acid in plasma, renal excretion of oxypurines and uric acid as well as plasma adenosine deaminase and AMP deaminase activity with essential hypertension (in Polish). Pol Arch Med Wewn 1993;89: 223-229.
30. Duprez D, De Buyzere M, Van Wasssenhove A, Clement D. Evaluation of the metabolic compensation after treadmill test in patients with peripheral occlusive arterial disease. Angiology 1992; 43:126-133.